%0 Journal Article
%T Alzheimer's disease drug development pipeline: 2019
%A Aaron Ritter
%A Garam Lee
%A Kate Zhong
%A Marwan Sabbagh
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2019
%R 10.1016/j.trci.2019.05.008
%X Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices
%K Alzheimer's disease
%K Drug development
%K Clinical trials
%K Biomarkers
%K Bayesian design
%K Adaptive design
%K Repurposed drugs
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617248/